Year: - Any -2023202220212020201920182017 Items per page 102550 Date Title Jul 27, 2021 Summary ToggleSol-Gel Technologies Announces FDA Approval of TWYNEO® Jul 20, 2021 Summary ToggleSol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021 Jun 28, 2021 Summary ToggleSol-Gel Announces Pipeline Update and Future Development Plans Jun 28, 2021 Summary ToggleSol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States May 27, 2021 Summary ToggleSol-Gel Technologies to Present at Upcoming Jefferies Healthcare Conference and Raymond James Human Health Innovation Conference May 13, 2021 Summary ToggleSol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update Apr 27, 2021 Summary ToggleSol-Gel Technologies Provides Update on FDA Review of EPSOLAY® Mar 04, 2021 Summary ToggleSol-Gel Technologies Reports Full Year 2020 Financial Results and Corporate Update Feb 24, 2021 Summary ToggleSol-Gel Technologies to Present at Upcoming 2021 Raymond James Institutional Investors Conference and H.C. Wainwright Global Life Sciences Conference Jan 11, 2021 Summary ToggleSol-Gel Technologies to Present at Upcoming 2021 Solebury Trout Virtual Investor Conference and H.C. Wainwright BioConnect Conference Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 … Next page Next Last page Last
Year: - Any -2023202220212020201920182017 Items per page 102550 Date Title Jul 27, 2021 Summary ToggleSol-Gel Technologies Announces FDA Approval of TWYNEO® Jul 20, 2021 Summary ToggleSol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021 Jun 28, 2021 Summary ToggleSol-Gel Announces Pipeline Update and Future Development Plans Jun 28, 2021 Summary ToggleSol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States May 27, 2021 Summary ToggleSol-Gel Technologies to Present at Upcoming Jefferies Healthcare Conference and Raymond James Human Health Innovation Conference May 13, 2021 Summary ToggleSol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update Apr 27, 2021 Summary ToggleSol-Gel Technologies Provides Update on FDA Review of EPSOLAY® Mar 04, 2021 Summary ToggleSol-Gel Technologies Reports Full Year 2020 Financial Results and Corporate Update Feb 24, 2021 Summary ToggleSol-Gel Technologies to Present at Upcoming 2021 Raymond James Institutional Investors Conference and H.C. Wainwright Global Life Sciences Conference Jan 11, 2021 Summary ToggleSol-Gel Technologies to Present at Upcoming 2021 Solebury Trout Virtual Investor Conference and H.C. Wainwright BioConnect Conference Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 … Next page Next Last page Last